Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin

Phytotherapy Research

Volumn 18, Issue 7, 2004, Pages 516-521

  Psotová, Jitka ^a   Chlopčíkova, Šárka ^a   Miketová, Petra ^a   Hrbác, Jan ^a   Šimánek, Vilím ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Cyclic voltammetry; Cytoprotection; Doxorubicin; Flavonoid; Lipid peroxidation; Rat cardiomyocytes; Scavenging effect

Indexed keywords

2,2 DIPHENYL 1 PICRYLHYDRAZYL RADICAL; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTHRACYCLINE ANTIBIOTIC AGENT; APIGENIN; BAICALEIN; CHELATING AGENT; DOXORUBICIN; FLAVONOID; KAEMPFEROL; LACTATE DEHYDROGENASE; LUTEOLIN; PHENOL DERIVATIVE; QUERCETIN; RADICAL; RAZOXANE; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIISCHEMIC ACTIVITY; ANTILIPOPEROXIDATIVE ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CARDIOTOXICITY; CELL CULTURE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPROTECTIVE ACTIVITY; DRUG ACTIVITY; DRUG EFFECT; HEART MITOCHONDRION; HEART MUSCLE CELL; IC 50; LIPID PEROXIDATION; MALE; MICROSOME; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; RAT; VASODILATING ACTIVITY;

ANIMALS; APIGENIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; FLAVONOIDS; FREE RADICAL SCAVENGERS; KAEMPFEROLS; LIPID PEROXIDATION; LUTEOLIN; MALE; MICROSOMES; MYOCYTES, CARDIAC; PHYTOTHERAPY; PICRATES; PLANTS, MEDICINAL; PROTECTIVE AGENTS; QUERCETIN; RATS; RATS, WISTAR;

EID: 4043174109     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1462     Document Type: Article

References (45)

1. Birt, DF, Hendrich S, Wang W. 2001. Dietary agents in cancer prevention. Flavonoids and isoflavonoids. Pharmacol Therap 90: 157-177.
2. Chan FL, Choi HL, Chen ZY, et al. 2000. Induction of apoptosis in prostate cancer cell lines by flavonoid, baicalin. Cancer Lett 160: 219-228.
3. Chen S. 1998. Aromatase and breast cancer. Front Biosci 3: 922-933.
4. Chlopčíková Š, Psotová J, Miketová P. 2001. Neonatal rat cardiomyocytes - a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed Papers 145: 49-55.
5. Chlopčíková Š, Psotová J, Miketová P, et al. 2004. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part II. Caffeic, chlorogenic and rosmarinic acids. Phytother Res 18: 408-413.
6. Constantinou A, Mehta R. Runyan C. 1995. Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships. J Nat Prod 58: 217-225.
7. Cotelle N, Bernier JL, Catteau JP, et al. 1996. Antioxidant properties of hydroxy-flavones. Free Rad Biol Med 20: 35-43.
8. Critchfield JW, Welsh CJ, Phang JM, Yeh GC. 1994. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 48: 1437-1445.
9. Deby C, Margotteaux G. 1970. Relationship between essential fatty acids and tissue antioxidant levels in mice. CR Soc Biol 164: 2675-2681.
10. De Groot H, Rauen U. 1998. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 12: 249-255.
11. Delgado G, del Socorro Olivares M, Chavez MI, et al. 2001. Antiinflammatory constituents from Heterotheca nuloides. J Nat Prod 64: 861-864.
12. Deschner EE, Ruperto J, Wong G, Newmark HZ. 1991. Quercetin and rutin as inhibitors of anoxymethanol-induced colonic neoplasia. Carcinogenesis 12: 1193-1196.
13. Di Carlo G, Mascolo N, Izzo AA, Capasso F. 1999. Flavonoids: old and new aspects of class of natural therapeutic drugs. Life Sci 65: 337-353.
14. Dorr RT. 1996. Cytoprotective agents for anthracyclines. Semin Oncol 23: 13-34.
15. Elangovan V, Sekar N, Govindasamy S. 1994. Chemopreventive potencial of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett 87: 107-113.
16. Fotsis T, Pepper MS, Aktas E, et al. 1997. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis Cancer Res 57: 2916-2921.
17. Freedman JE, Parker C 3rd, Li L, et al. 2001. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103: 2792-2798.
18. Gee JM, Johnson IT. 2001. Polyphenolic compounds: Interactions with the gut and implications for human health. Curr Med Chem 8: 1245-1255.
19. Giugliano D. 2000. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovaso Dis 10: 38-44.
20. Hasinoff BB, Hellmann K, Herman EH, Ferrans VJ. 1998. Chemical; biological and clinical aspects of dexrazoxane and other bisdioxopiperazines. Curr Med Chem 5: 1-28.
21. Ikegawa T, Ohtani H, Koyabu N, et al. 2002. Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett 177: 89-93.
22. Ikemoto S, Sugimura K, Yoshida N, et al. 2000. Antitumor effects of Scutelalariae radix and its components baicalein; baicalin; and wogonin on bladder cancer lines. Urology 55: 951-955.
23. Joyeux M, Lobstein A, Anton R, Mortier F. 1995. Comparative antilipoperoxidant; antinecotic and scavengng properties of terpenes and biflavones from Ginkgo and some flavonoids. Planta Med 61: 126-129.
24. Kaneko T, Kaii K, Matsuo M. 1994. Protection of linoleic acid hydroperoxide-induced cytotoxicity by phenolic antioxidants. Free Rad Biol Med 16: 405-409.
25. Kao YC, Zhou C, Sherman M, et al. 1998. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect 106: 85-92.
26. Kimata M, Inagaki N, Nagai H. 2000. Effect of luteolin and the other flavonoids on IgE-mediated allergic reactions. Planta Med 66: 25-29.
27. Korkina LG, Afans'ev IB. 1997. Antioxidant and chelating properties of flavonoids. In Advances in Pharmacology, Sies H (ed.). Academic Press: San Diego CA; 151-163.
28. Legha SS, Wang YM, Mackay B, et al. 1982. Clinical and pharmacologic investigation of the effects of alphatocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci 393: 411-418.
29. Li BQ, Fu T, Dongyan Y, et al. 2000. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun 276: 534-538.
30. Middleton E. 1998. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exper Med Biol 439: 175-182.
31. Minotti G, Cairo G, Monti E. 1999. Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J 13: 199-212.
32. Monline J, Bukharovich IF, Wolff MS, Phillips R. 2000. Dietary flavonoids and hypertension: is there a link? Med Hypotheses 55: 306-309.
33. Myers C, Bonow R, Palmeri S, et al. 1983. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 10: 53-55.
34. Nagata C, Takatsuka N, Shimizxu H, et al. 2001. Effect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men. Cancer Epidemiol Biomarkers Prev 10: 179-184.
35. Psotová J, Chlopčífková Š, Grambal F, et al. 2002. Influence of silymarin and its flavonolignans on doxorubicin-iron induced lipid peroxidation in rat heart microsomes and mitochondria in comparison with quercetin. Phytother Res 10: S63-S67.
36. Rice-Evans C. 2001. Flavonoid antioxidants. Curr Med Chem 8: 797-807.
37. Riemersma RA, Rice-Evans CA, Tyrrell RM, et al. 2001. Tea flavonoids and cardiovascular health. QJM 94: 277-282.
38. Russo M, Palumbo R, Tedesco I, et al. 1999. Quercetin and anti-CD95 (Fas/Apol) enhance apoptosis in HPB-ALL cell line. FEBS Lett 462: 322-328.
39. Scambia G, Ranelletti FO, Benedetti Panici P, et al. 1991. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol 28: 255-258.
40. Scambia G, Ranelletti FO, Benedetti Panici P, et al. 1992. Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (11). Gynecol Oncol 45: 13-19.
41. Shapiro AB, Ling V. 1997. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. 1997. Biochem Pharmacol 53: 587-596.
42. Thomas CE, McLean LR, Parker PA, Ohlweiler DF. 1992. Ascorbate and phenolic antioxidant interactions in prevention of liposomal oxidation. Lipids 27: 543-550.
43. Van Acker SABE, Van den Berg DJ, Tromp MNJL, et al. 1996. Structural aspects of antioxidant activity of flavonoids. Free Rad Biol Med 20: 331-342.
44. Van Acker SA, Boven E, Kuiper K, et al. 1997. Monohydroxyethylrutoside; a dose-dependent cardioprotective agent; does not effect the antitumor activity of doxorubicin. Clin Cancer Res 3: 1747-1754.
45. Van Acker SABE, Van Balen GP, Van den Berg DJ, et al. 1998. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 56: 935-943.